AI English summary of an SEC filing — figures as filed
Vertex Pharmaceuticals VRTXThe company said it entered into amendments on August 15, 2024 with SNH Seaport LLC to its headquarters leases for 50 Northern Avenue and 11 Fan Pier Boulevard in Boston, each dated May 5, 2011.
Key points
AI summaryThe company said it entered into amendments on August 15, 2024 with SNH Seaport LLC to its headquarters leases for 50 Northern Avenue and 11 Fan Pier Boulevard in Boston, each dated May 5, 2011.
The company said it leases a combined approximately 1.1 million square feet of office and laboratory space across two buildings.
The company said the amendments extend the lease terms from December 2028 (with 10-year extension options) to June 30, 2044.
The company said it has the option to extend for up to two additional ten-year periods after June 30, 2044, and that the lease amendments will be filed with a subsequent Form 10-Q quarterly report.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Vertex Enters Amendments to Headquarters Leases
The company said it entered into amendments on August 15, 2024 with SNH Seaport LLC to its headquarters leases for 50 Northern Avenue and 11 Fan Pier Boulevard in Boston, each dated May 5, 2011.
Source · Based on the filing body and exhibits
Leased Area and Facility Mix
The company said it leases a combined approximately 1.1 million square feet of office and laboratory space across two buildings.
Source · Based on the filing body and exhibits
Lease Term Extension
The company said the amendments extend the lease terms from December 2028 (with 10-year extension options) to June 30, 2044.
Source · Based on the filing body and exhibits
Additional Extension Options
The company said it has the option to extend for up to two additional ten-year periods after June 30, 2044, and that the lease amendments will be filed with a subsequent Form 10-Q quarterly report.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…